Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis

Based on an estimation of 10-year CVD risk using QRISK2 in a sample of English population aged 30-84 years, under the 2014 NICE guidelines, 11.8 million (37%) adults in England, including 95% of males and 66% of females without CVD in ages 60–74 years qualify for statin therapy.

The 2014 guidelines on cardiovascular risk assessment and lipid modification from the National Institute for Health and Care Excellence (NICE) recommend statin therapy for adults with prevalent cardiovascular disease (CVD), and for adults with a 10-year CVD risk of ≥10%, estimated using the QRISK2 algorithm.

 

The NICE guidelines were applied to the sample using data from the Health Survey for England 2011.